Monday, December 23, 2024
HomeTagsInnovative Monoclonal

Innovative Monoclonal

Henlius Receives NMPA Approval for its First Innovative Monoclonal Antibody HANSIZHUANG

Shanghai Henlius Biotech, Inc. announced that its first self-developed innovative PD-1 inhibitor HANSIZHUANG has been approved by the National Medical Products Administration (NMPA) for...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics